A previous study mentioned that bone metastasis is a significant independent negative predictive factor for overall survival (OS) in lung cancer patients with mutated as well as wild-type epidermal growth factor receptor (EGFR) whereas lung or brain metastasis was not involved in OS, which is also suggesting the importance of managing bone metastasis [6]. This evidence concerns the gene EGFR and bone metastasis.